Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1

Conditions

Polycystic Ovary Syndrome 35Insulin Resistance 6Infertility 6Hyperandrogenism 3Anovulation 3Pre-Eclampsia 2Metabolic Syndrome 2Infertility, Female 2Glucose Intolerance 2Diabetes, Gestational 2Carcinoma, Non-Small-Cell Lung 2Weight Loss 1Thyroid Nodule 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Premature Birth 1Precancerous Conditions 1Periodontitis 1Oligomenorrhea 1Menstruation Disturbances 1Lung Neoplasms 1Inflammation 1Hodgkin Disease 1Colonic Neoplasms 1Amenorrhea 1

Interventions

Etoposide 156Carboplatin 146Cisplatin 106Topotecan 76durvalumab 52atezolizumab 51Irinotecan 45pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 31PM 01183 25Drug Therapy 24anlotinib 23Gemcitabine 21apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Magnetic Resonance Spectroscopy 13Bevacizumab 13rovalpituzumab tesirine 11amrubicin 11Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Inositol × Clear all
NCT00061997 2010-02-02

Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers

National Cancer Institute (NCI)

Phase 1 Completed
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡